CWM
SANA icon

CIBC World Markets’s Sana Biotechnology SANA Stock Holding History

CIBC World Markets’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$44.5K Buy
+10,930
New +$48.9K ﹤0.01% 1201
2025
Q2 		$44.9K Sell
16,439
-12,896
-44% -$26.6K ﹤0.01% 1484
2025
Q1 		$49.3K Buy
29,335
+16,963
+137% +$47.4K ﹤0.01% 1719
2024
Q4 		$20.2K Buy
+12,372
New +$36.9K ﹤0.01% 1305

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

CIBC World Markets's SANA Position: Q4 2025 in Review

CIBC World Markets opened a new position in Sana Biotechnology (SANA) in Q4 2025: 10,930 shares worth $44.5K. The stake represents ﹤0.01% of the portfolio and ranks #1201 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in SANA as recently as Q2 2025.

CIBC World Markets first reported a position in SANA in Q4 2024 and has held it in 4 quarters since. The position peaked at $49.3K in Q1 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • CIBC World Markets held 10,930 shares of Sana Biotechnology worth $44.5K as of Q4 2025.
  • Sana Biotechnology was a new CIBC World Markets position in Q4 2025.
  • Sana Biotechnology made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1201 holding.
  • CIBC World Markets first reported a position in Sana Biotechnology in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Sana Biotechnology position peaked at $49.3K in Q1 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.